Navigation Links
Drug Reduces Complications in Surgical Abortions: Study
Date:3/7/2012

WEDNESDAY, March 7 (HealthDay News) -- The drug misoprostol reduced major complications from early surgical abortion by nearly one-third, according to a new study.

Doctors often use misoprostol for cervical preparation prior to surgical abortion (vacuum aspiration). Until now, however, there were no studies large enough to determine whether the drug reduces the risk of serious complications, either immediate or delayed, according to background information in the study published in the March 8 online edition of The Lancet.

For the study, researchers from the World Health Organization (WHO) in Geneva compared rates of complications among nearly 5,000 women in nine countries who underwent surgical abortion before 12 weeks of gestation. Complications included cervical tear, uterine perforation, incomplete abortion and pelvic inflammatory disease.

Women were randomly assigned to receive either vaginal misoprostol or an inactive "placebo" three hours before the procedure.

The women in the misoprostol group were nearly one-third less likely to experience one or more complications compared to the women who received a placebo, and the risk of incomplete abortion was nearly three times higher among the women in the placebo group, the investigators found.

Women in the misoprostol group, however, were more likely to experience abdominal pain, vaginal bleeding and nausea in the three hours before surgery.

"Misoprostol reduced the overall incidence of complications, particularly incomplete abortions and unscheduled clinic visits and hospital admissions, after abortion," concluded study author Eduardo Bergel and colleagues, in a journal news release. "Providers should be aware of the side effects of the drug and inform women about these effects."

In an accompanying editorial, Dr. Allan Templeton, professor of obstetrics and gynecology at the University of Aberdeen in Scotland, wrote: "The important ongoing issue is . . . the balance between effectiveness of the procedure and the side effects of misoprostol, which will include abdominal cramps and vaginal bleeding in most women, although not to the extent of needing medical intervention before surgery."

The findings of this study suggest that "routine pharmaceutical dilation of the cervix should be recommended as an integral part of surgical abortion in all women," Templeton added.

More information

The U.S. National Library of Medicine has more about surgical abortion.

-- Robert Preidt

SOURCE: The Lancet, news release, March 7, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Service Foods Reduces its Carbon Footprint and Grows Sales
2. Health Care Reform Report Covers Uninsured, Reduces Costs
3. New cardiac CT technology drastically reduces patient radiation exposure
4. Accelerated radiation therapy reduces toxicity in patients with advanced head and neck cancers
5. Targeted delivery of losartan reduces liver inflammation and scarring
6. Drug dramatically reduces nausea and vomiting in bone marrow transplant patients
7. Soccer reduces risk of falls and bone fractures
8. Pioneering treatment reduces disability in premature babies with serious brain hemorrhage
9. New drug candidate reduces blood lipids
10. PSA Test Reduces Prostate Cancer Deaths by 40%
11. New technique reduces tobacco smoke damage to lungs in mice
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug Reduces Complications in Surgical Abortions: Study
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Consumers have ... and regulators/payers have placed more emphasis on patient ... patient support programs in the pharmaceutical industry have ... medications. Consequently, pharmaceutical companies are focusing on becoming ... are providing products and services that improve health. ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
Breaking Medicine Technology: